Wilfred A Nix1, Rudolf Zirwes2, Volkhard Bangert2, Raimund Peter Kaiser3, Matthias Schilling4, Ulrike Hostalek5, Rima Obeid6. 1. Akademie für Ärztliche Fortbildung in Rheinland-Pfalz, Mainz, Germany. Electronic address: nix@arztkolleg.de. 2. Private Practice, Daun, Germany. 3. Private Practice, Kelberg, Germany. 4. Private Practice, Wittlich, Germany. 5. Merck KGaA, Darmstadt, Germany. 6. Aarhus Institute of Advanced Studies, Aarhus University, D-8000, Aarhus C, Denmark.
Abstract
AIM: To investigate the vitamin B status, with particular focus on vitamin B6, in adults with and without incipient nephropathy secondary to type 2 diabetes mellitus. METHODS: Plasma and/or urine concentrations of vitamins B₆, B₁, B₁₂, related vitamers and biomarkers (including total homocysteine, methylmalonic acid) were measured in 120 adults with type 2 diabetes (including 46 patients with microalbuminuria) and 52 non-diabetic control subjects. RESULTS: Plasma concentrations of pyridoxal 5'-phosphate (PLP) were significantly lower in patients with type 2 diabetes than in control subjects (median: 22.7 nmol/L, diabetes with microalbuminuria; 26.8 nmol/L, diabetes without microalbuminuria; 39.5 nmol/L, non-diabetic control; p<0.0001). The prevalence of low PLP (<30 nmol/L) was 63%, 58%, and 25% in the diabetes groups with and without microalbuminuria and the control group, respectively. Plasma levels of pyridoxine and pyridoxal were also lower (p<0.0001), but levels of pyridoxamine, pyridoxamine 5'-phosphate, and pyridoxic acid were higher in both groups with diabetes compared to the control group (p<0.001). Thiamine deficiency was highly prevalent in all groups, whereas low vitamin B₁₂ and elevated methylmalonic acid were rare. Increased levels of C-reactive protein and soluble vascular cell adhesion molecule-1 were observed in the groups with diabetes (p<0.05, versus healthy control). CONCLUSIONS: Deficiency of vitamin B₆ (PLP, pyridoxine, pyridoxal) and vitamin B₁ (thiamine) was prevalent in type 2 diabetes. Incipient nephropathy was associated with more pronounced alterations in vitamin B₆ metabolism and stronger indications of endothelial dysfunction and inflammation.
AIM: To investigate the vitamin B status, with particular focus on vitamin B6, in adults with and without incipient nephropathy secondary to type 2 diabetes mellitus. METHODS: Plasma and/or urine concentrations of vitamins B₆, B₁, B₁₂, related vitamers and biomarkers (including total homocysteine, methylmalonic acid) were measured in 120 adults with type 2 diabetes (including 46 patients with microalbuminuria) and 52 non-diabetic control subjects. RESULTS: Plasma concentrations of pyridoxal 5'-phosphate (PLP) were significantly lower in patients with type 2 diabetes than in control subjects (median: 22.7 nmol/L, diabetes with microalbuminuria; 26.8 nmol/L, diabetes without microalbuminuria; 39.5 nmol/L, non-diabetic control; p<0.0001). The prevalence of low PLP (<30 nmol/L) was 63%, 58%, and 25% in the diabetes groups with and without microalbuminuria and the control group, respectively. Plasma levels of pyridoxine and pyridoxal were also lower (p<0.0001), but levels of pyridoxamine, pyridoxamine 5'-phosphate, and pyridoxic acid were higher in both groups with diabetes compared to the control group (p<0.001). Thiamine deficiency was highly prevalent in all groups, whereas low vitamin B₁₂ and elevated methylmalonic acid were rare. Increased levels of C-reactive protein and soluble vascular cell adhesion molecule-1 were observed in the groups with diabetes (p<0.05, versus healthy control). CONCLUSIONS: Deficiency of vitamin B₆ (PLP, pyridoxine, pyridoxal) and vitamin B₁ (thiamine) was prevalent in type 2 diabetes. Incipient nephropathy was associated with more pronounced alterations in vitamin B₆ metabolism and stronger indications of endothelial dysfunction and inflammation.
Authors: Eliza Fraszczyk; Chris H L Thio; Paul Wackers; Martijn E T Dollé; Vincent W Bloks; Hennie Hodemaekers; H Susan Picavet; Marjolein Stynenbosch; W M Monique Verschuren; Harold Snieder; Annemieke M W Spijkerman; Mirjam Luijten Journal: Geroscience Date: 2022-08-10 Impact factor: 7.581
Authors: Gerwyn Morris; Michael Berk; Andre Carvalho; Javier R Caso; Yolanda Sanz; Ken Walder; Michael Maes Journal: Mol Neurobiol Date: 2016-06-27 Impact factor: 5.590
Authors: Nathalie Mangel; Jared B Fudge; Wilhelm Gruissem; Teresa B Fitzpatrick; Hervé Vanderschuren Journal: Front Plant Sci Date: 2022-04-04 Impact factor: 6.627
Authors: Jasmine F Plows; Florence Budin; Rebecka A M Andersson; Valerie J Mills; Katherine Mace; Sandra T Davidge; Mark H Vickers; Philip N Baker; Irma Silva-Zolezzi; Joanna L Stanley Journal: Nutrients Date: 2017-02-15 Impact factor: 5.717